Discovery of selective irreversible inhibitors for EGFR-T790M

被引：56

作者：

Zhou, Wenjun ^{[1
,2
]}

Ercan, Dalia ^{[3
,4
]}

Jaenne, Pasi A. ^{[3
,4
,5
]}

Gray, Nathanael S. ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[5] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期

关键词：

EGFR; Kinase inhibitor; T790M; Mutant selective; ACQUIRED-RESISTANCE; KINASE INHIBITORS; EGFR; RECEPTOR; CANCER;

D O I：

10.1016/j.bmcl.2010.12.036

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Targeting the epidermal growth factor receptor kinase (EGFR) with ATP-competitive kinase inhibitors results in dramatic but short-lived responses in patients with EGFR mutant non small cell lung cancer. A series of novel covalent EGFR kinase inhibitors with selectivity for the clinically relevant T790M 'gatekeeper' resistance mutation relative to wild-type EGFR were discovered by library screening. A representative compound 3i was obtained through a systematic SAR study guided by mutant EGFR-dependent cellular proliferation assays. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：638 / 643

页数：6

共 50 条

[1] Discovery of novel selective inhibitors for EGFR-T790M/L858R
Bai, Fang
Liu, Hongyan
Tong, Linjiang
Zhou, Wei
Liu, Li
Zhao, Zhenjiang
Liu, Xiaofeng
Jiang, Hualiang
Wang, Xicheng
Xie, Hua
Li, Honglin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1365 - 1370
[2] Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors
Zhang, Long
Yang, Yingying
Zhou, Haojie
Zheng, Qingmei
Li, Yuhao
Zheng, Shansong
Zhao, Shuyong
Chen, Dong
Fan, Chuanwen
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 : 445 - 463
[3] Reducing proteome reactivity of irreversible inhibitors of EGFR T790M
Kath, John
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[4] In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features
Xiang, Mingli
Lei, Kai
Fan, Wenjie
Lin, Yuchun
He, Gu
Yang, Mingli
Chen, Lijuan
Mo, Yirong
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 789 - 839
[5] Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers
Gaber, Ahmed A.
Sharaky, Marwa
Abo Elmaaty, Ayman
Hammouda, Mohamed M.
Mourad, Ahmed A. E.
Elkhawaga, Samy Y.
Mokhtar, Mahmoud Mohamed
Abouzied, Amr S.
Mourad, Mai A. E.
Al-Karmalawy, Ahmed A.
FUTURE MEDICINAL CHEMISTRY, 2023, 15 (19) : 1773 - 1790
[6] AfatinibResistance due to EGFR-T790M resistance mutation: case report
Reactions Weekly, 2018, 1715 (1) : 22 - 22
[7] The novel detection of the EGFR-T790M mutation in exhaled breath condensate
Smyth, R.
Toomey, S.
Sartori, A.
O'Hanrahan, E.
Cuffe, S.
Breathnach, O.
Morgan, R.
Hennessy, B.
CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 170 - 171
[8] In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors
Asadollahi-Baboli, M.
MOLECULAR DIVERSITY, 2016, 20 (03) : 729 - 739
[9] In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors
M. Asadollahi-Baboli
Molecular Diversity, 2016, 20 : 729 - 739
[10] Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Zhou, Wenjun
Ercan, Dalia
Chen, Liang
Yun, Cai-Hong
Li, Danan
Capelletti, Marzia
Cortot, Alexis B.
Chirieac, Lucian
Iacob, Roxana E.
Padera, Robert
Engen, John R.
Wong, Kwok-Kin
Eck, Michael J.
Gray, Nathanael S.
Jaenne, Pasi A.
NATURE, 2009, 462 (7276) : 1070 - 1074

← 1 2 3 4 5 →